Wonderful Sky Financial Group Assists BGI Genomics Co., Ltd. (300676.SZ) with Successful Listing on SZSE
On 14 July 2017, BGI Genomics Co., Ltd. (hereinafter “BGI Genomics” or the “Company”) was duly listed for trading on the GEM Board of the Shenzhen Stock Exchange, and the stock code is “300676”.
BGI Genomics adheres to the vision of “Gene Technology Benefitting Human Beings”, regarding promotion of life science research and progress as well as enhancement of global healthcare standards as the starting point. Based on the research results in the scope of genes and the application of biotechnology in healthcare of human, BGI Genomics carries out scientific research and industrial layout, strives to accelerate scientific innovation, reduces birth defects, strengths prevention and control of tumors, restrains substantial diseases harming human beings, achieves precise treatment of infection, and assists in accurate medical science. The principal business of the Company is provision of diagnosis and research services of genomics for medical institutions, scientific research institutions, enterprise and public institutions through measures such as genetic testing. By relying upon the global leading R&D, transformation and application platform of biological information, over a hundred of high-tech NGS apparatus, mass spectrometers and large-scale computers, the Company provides strong protection for output, storage and analysis of information.
The headquarters of the Company are located in Shenzhen, the PRC. Branches and medical examination institutes are established in major cities in mainland China, such as Beijing, Tianjin, Wuhan, Shanghai and Guangzhou, while overseas centers and core laboratories are established in several regions such as Hong Kong, Europe, America and Asia-Pacific region, forming a network layout of “covering the entire country, expanding to the world”. The Company mainly caters to institutes such as domestic and overseas scientific research colleges, research institutes, independent laboratories and pharmaceutical companies, as well as healthcare institutes such as domestic and overseas hospital in different levels and medical examination institutes, customers of the Company and public customers, currently covering over 100 nations and regions in the world, including over 2,000 scientific research institutes and over 2,300 medical institutes in 31 provinces, cities and autonomous regions in mainland China, among which over 300 grade A class three hospitals are covered. The Company also cooperates with more than 3,000 overseas medical and scientific research institutes in regions such as Europe, America and Oceania.
As the only large-scale integrated financial communications group in the world listed on the HKEx, Wonderful Sky will continue to provide a high-quality "one-stop” and nine-in-one financial public relations services, including financial public relations, investor relations, international roadshows, financial printing, branding and innovation, ESG reports, asset management, corporate doctor and headhunting program. Moreover, Wonderful Sky will adhere to the mission of “Your Success is Our Inspiration” to become the long-term premium partner of listed companies by offering tailored services to each of the clients.